Wayne C. Schairer

Inhibitors of hepatitis C virus NS3·4A protease. Part 3: P2 proline variants

Robert B. Perni, Luc J. Farmer, Kevin M. Cottrell et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 52 citations · Full text

Viral Hepatitis, Antiviral Drug Development, Antiviral Therapy +9

Discovery and Characterization of a Potent Interleukin-6 Binding Peptide with Neutralizing Activity In Vivo

Sheila Ranganath, Ashok Bhandari, Nicole Avitahl-Curtis et al. · PLoS ONE · 2015 · 42 citations · Full text

Immunology, Kda Polyethylene Glycol, Neutralizing Activity +17

Inhibitors of hepatitis C virus NS3·4A protease 1. Non-Charged tetrapeptide variants

Robert B. Perni, Shawn Britt, John C. Court et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 39 citations · Full text

Non-charged Tetrapeptide Variants, Viral Hepatitis, Immunology +10

Design and synthesis of novel conformationally restricted HIV protease inhibitors

Francesco G. Salituro, Christopher Baker, John J. Court et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 37 citations · Full text

Combinatorial Chemistry, Biochemistry, Medicine +7

Inhibitors of hepatitis C virus NS3·4A protease. Effect of P4 capping groups on inhibitory potency and pharmacokinetics

Robert B. Perni, Gurudatt Chandorkar, Kevin M. Cottrell et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 17 citations

Viral Hepatitis, Medicine, Antiviral Drug Development +9